Flamini, Robert
GW Pharmaceuticals (United Kingdom)
2 papers on CoChatORCID 0000-0001-5095-3166
Most cited papers
- Verified
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
Thiele, E. A., Marsh, E. D., French, J. A., Mazurkiewicz-Beldzinska, M., Benbadis, S. R., Joshi, C., Lyons, P. D., Taylor, A., Roberts, C., Sommerville, K., et al. (2018) · The Lancet
Epilepsy research and treatmentCannabis and Cannabinoid Research
Cited by 905
- Verified
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
Devinsky, O., Marsh, E., Friedman, D., Thiele, E., Laux, L., Sullivan, J., Miller, I., Flamini, R., Wilfong, A., Filloux, F., et al. (2016) · The Lancet Neurology
Epilepsy research and treatmentCannabis and Cannabinoid Research
Cited by 900
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free